Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

MEC Basic Full List View

By pinki@katapult.biz / February 16, 2025

MEC Basic

Speciality

Author / Speaker

Title

Type of Media

Events

Search Entries:

«
1
…
69
70
71
72
73
74
»

Squamous Cell Carcinoma: What are the Standards and Potential Pathways in Development

Squamous Cell Carcinoma: What are the Standards and Potential Pathways in Development

Luis Corrales-Rodriguez, MD

Treatment of Early-Stage HER2+ Breast Cancer

Treatment of Early-Stage HER2+ Breast Cancer

Chau T. Dang, MD

Acute Myeloid and Lymphoid Leukemias

Acute Myeloid and Lymphoid Leukemias

Hugo F. Fernandez, MD

Prostate Cancer Management

Prostate Cancer Management

Mayer Fishman, MD, PhD

Ovarian cancer: Contemporary Management & Clinical Trial Endpoint Considerations

Ovarian cancer: Contemporary Management & Clinical Trial Endpoint Considerations

Thomas J. Herzog, MD

Immunotherapy in Head and Neck Cancer and MSI in Solid Tumors

Immunotherapy in Head and Neck Cancer and MSI in Solid Tumors

Brian Hunis, MD, MBA

CLL & CML

Mohamed A. Kharfan-Dabaja, MD, MBA

Colorectal Cancer: Novel Insights

Colorectal Cancer: Novel Insights

Richard Kim, MD

Immunotherapy for the Treatment of Kidney and Bladder Cancer

Immunotherapy for the Treatment of Kidney and Bladder Cancer

Alan J. Koletsky, MDky, MD

Novel Therapies in Metastatic Kidney Cancer

Novel Therapies in Metastatic Kidney Cancer

Primo N. Lara, Jr., MD

Melanoma: What Else Beyond Checkpoint Inhibitor Pathway?

Melanoma: What Else Beyond Checkpoint Inhibitor Pathway?

Jose Lutzky, MD, FACP

Supportive Care Reality vs. Perception

Supportive Care Reality vs. Perception

Jessica MacIntyre, ARNP, NP-C, AOCNP

Cancer Treatment Induced Bone Loss (CTIBL)_ RANK Ligand, Bisphosphonate, Anti-angiogenesis, and More

Cancer Treatment Induced Bone Loss (CTIBL)_ RANK Ligand, Bisphosphonate, Anti-angiogenesis, and More

Robert E. Marx, DDS

Integrative Oncology: Evidence-Based Supportive Care for Patients during Treatment and Survivorship

Integrative Oncology: Evidence-Based Supportive Care for Patients during Treatment and Survivorship

Ashwin Mehta, MD, PhD

Familial Hereditary Symdromes in High-risk Breast Cancer Patients_ Genetic Counseling

Familial Hereditary Symdromes in High-risk Breast Cancer Patients_ Genetic Counseling

Louise Morrell, MD

Marijuana Use in Cancer: Myths and Reality

Marijuana Use in Cancer: Myths and Reality

Dov Pickholtz, DO

Other Driver Mutations: cMET, B-RAF, RET, NTRK

Other Driver Mutations: cMET, B-RAF, RET, NTRK

Luis E. Raez, MD, FACP, FCCP

Pancreatic, Biliary, and HCC Update

Pancreatic, Biliary, and HCC Update

Caio Max S. Rocha Lima, MD

EGFR & ALK: Where are We Now

EGFR & ALK: Where are We Now

Edgardo S. Santos, MD, FACP

Health, Wellness and Cancer Prevention

Health, Wellness and Cancer Prevention

Orlando E. Silva, MD

Targeted Therapy for B- and T-cell Non-Hodgkin's Lymphomas

Targeted Therapy for B- and T-cell Non-Hodgkin's Lymphomas

Eduardo M. Sotomayor, MD

Novel Therapies for BCC and SCC of Skin and Merkel Cell Carcinoma

Novel Therapies for BCC and SCC of Skin and Merkel Cell Carcinoma

John Strasswimmer, MD, PhD

Chemotherapy and Hormonal Therapy in the Metastatic Setting, ER+ HER2-2- and TNBC

Chemotherapy and Hormonal Therapy in the Metastatic Setting, ER+ HER2-2- and TNBC

Vicente Valero, MD, FACP

Immunotherapy in Colorectal Cancer

Immunotherapy in Colorectal Cancer

Ahmed Zakari, MD

Case Study Immunotherapy

Case Study Immunotherapy

Gandara, David, MD

Displaying 1,751 - 1,775 of 1,833

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok